Status:
COMPLETED
A Study to Determine Whether Urinary PGE-M Levels Correlate With Ulcerative Colitis Disease
Lead Sponsor:
Vanderbilt University
Collaborating Sponsors:
Procter and Gamble
Conditions:
Ulcerative Colitis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether urinary PGE-M levels correlate with Ulcerative Colitis Disease activity and to compare how well urinary PGEm correlates with other noninvasive biomark...
Detailed Description
The available clinical measures of ulcerative colitis activity can be overly influenced by functional symptoms. Placebo response rates in clinical trials are high. Several non-invasive biomarkers are ...
Eligibility Criteria
Inclusion
- Outpatient male or female 18 years or older
- Confirmed diagnosis of ulcerative colitis
- Informed consent obtained
- Able to give blood, urine and stool samples
- Will undergo a diagnostic colonoscopy of part of routine Ulcerative Colitis care
Exclusion
- Unable to give consent
- Crohn's disease
- Does not meet inclusion criteria
- Pregnant
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT00409396
Start Date
November 1 2006
End Date
December 1 2007
Last Update
June 9 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37232